Ase & Bio
Records under this name other than patents Ase & Bio holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 2 of 2 · Back to Ase & Bio
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,367,641 | Use of modified oligo-β-(1,3)-glucans for treating diseases of the immune system, oligo-β-(1,3)-glucan-(1,3)-mannose, oligo-β-(1,3)-glucan-(1,3)-mannitol and derivatives thereof, methods for preparing them and medicaments containing them Lapsed on the fee record Ended Feb 5, 2017 · USPTO record | Lapsed on the fee record | Ended Feb 5, 2017 | USPTO record |
| US 8,288,363 | Medicaments for anti-herpes virus treatments Lapsed on the fee record Ended Oct 16, 2016 · USPTO record | Lapsed on the fee record | Ended Oct 16, 2016 | USPTO record |